These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1026 related articles for article (PubMed ID: 27049944)

  • 1. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression.
    Seifert L; Werba G; Tiwari S; Giao Ly NN; Alothman S; Alqunaibit D; Avanzi A; Barilla R; Daley D; Greco SH; Torres-Hernandez A; Pergamo M; Ochi A; Zambirinis CP; Pansari M; Rendon M; Tippens D; Hundeyin M; Mani VR; Hajdu C; Engle D; Miller G
    Nature; 2016 Apr; 532(7598):245-9. PubMed ID: 27049944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RIP3 promotes colitis-associated colorectal cancer by controlling tumor cell proliferation and CXCL1-induced immune suppression.
    Liu ZY; Zheng M; Li YM; Fan XY; Wang JC; Li ZC; Yang HJ; Yu JM; Cui J; Jiang JL; Tang J; Chen ZN
    Theranostics; 2019; 9(12):3659-3673. PubMed ID: 31281505
    [No Abstract]   [Full Text] [Related]  

  • 3. RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer.
    Wang W; Marinis JM; Beal AM; Savadkar S; Wu Y; Khan M; Taunk PS; Wu N; Su W; Wu J; Ahsan A; Kurz E; Chen T; Yaboh I; Li F; Gutierrez J; Diskin B; Hundeyin M; Reilly M; Lich JD; Harris PA; Mahajan MK; Thorpe JH; Nassau P; Mosley JE; Leinwand J; Kochen Rossi JA; Mishra A; Aykut B; Glacken M; Ochi A; Verma N; Kim JI; Vasudevaraja V; Adeegbe D; Almonte C; Bagdatlioglu E; Cohen DJ; Wong KK; Bertin J; Miller G
    Cancer Cell; 2018 Nov; 34(5):757-774.e7. PubMed ID: 30423296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cIAP1 and cIAP2 limit macrophage necroptosis by inhibiting Rip1 and Rip3 activation.
    McComb S; Cheung HH; Korneluk RG; Wang S; Krishnan L; Sad S
    Cell Death Differ; 2012 Nov; 19(11):1791-801. PubMed ID: 22576661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury.
    Deutsch M; Graffeo CS; Rokosh R; Pansari M; Ochi A; Levie EM; Van Heerden E; Tippens DM; Greco S; Barilla R; Tomkötter L; Zambirinis CP; Avanzi N; Gulati R; Pachter HL; Torres-Hernandez A; Eisenthal A; Daley D; Miller G
    Cell Death Dis; 2015 May; 6(5):e1759. PubMed ID: 25950489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance.
    Daley D; Mani VR; Mohan N; Akkad N; Ochi A; Heindel DW; Lee KB; Zambirinis CP; Pandian GSB; Savadkar S; Torres-Hernandez A; Nayak S; Wang D; Hundeyin M; Diskin B; Aykut B; Werba G; Barilla RM; Rodriguez R; Chang S; Gardner L; Mahal LK; Ueberheide B; Miller G
    Nat Med; 2017 May; 23(5):556-567. PubMed ID: 28394331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CYLD deubiquitinates RIP1 in the TNFα-induced necrosome to facilitate kinase activation and programmed necrosis.
    Moquin DM; McQuade T; Chan FK
    PLoS One; 2013; 8(10):e76841. PubMed ID: 24098568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PI3K mediates tumor necrosis factor induced-necroptosis through initiating RIP1-RIP3-MLKL signaling pathway activation.
    Hu S; Chang X; Zhu H; Wang D; Chen G
    Cytokine; 2020 May; 129():155046. PubMed ID: 32114297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome inhibitor PS-341 limits macrophage necroptosis by promoting cIAPs-mediated inhibition of RIP1 and RIP3 activation.
    Zhang Y; Cheng J; Zhang J; Wu X; Chen F; Ren X; Wang Y; Li Q; Li Y
    Biochem Biophys Res Commun; 2016 Sep; 477(4):761-767. PubMed ID: 27363341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shikonin induces glioma cell necroptosis in vitro by ROS overproduction and promoting RIP1/RIP3 necrosome formation.
    Lu B; Gong X; Wang ZQ; Ding Y; Wang C; Luo TF; Piao MH; Meng FK; Chi GF; Luo YN; Ge PF
    Acta Pharmacol Sin; 2017 Nov; 38(11):1543-1553. PubMed ID: 28816233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Necroptosis in Ligand-Mediated and Hypoxia-Induced Injury of Hepatocytes Using a Novel Optic Probe-Detecting Receptor-Interacting Protein (RIP)1/RIP3 Binding.
    Haga S; Kanno A; Ozawa T; Morita N; Asano M; Ozaki M
    Oncol Res; 2018 Apr; 26(3):503-513. PubMed ID: 28770700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 35 Expression Correlates With Microvessel Density in Pancreatic Ductal Adenocarcinoma, Recruits Monocytes, and Promotes Growth and Angiogenesis of Xenograft Tumors in Mice.
    Huang C; Li Z; Li N; Li Y; Chang A; Zhao T; Wang X; Wang H; Gao S; Yang S; Hao J; Ren H
    Gastroenterology; 2018 Feb; 154(3):675-688. PubMed ID: 28989066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concerted cell and in vivo screen for pancreatic ductal adenocarcinoma (PDA) chemotherapeutics.
    Layeghi-Ghalehsoukhteh S; Pal Choudhuri S; Ocal O; Zolghadri Y; Pashkov V; Niederstrasser H; Posner BA; Kantheti HS; Azevedo-Pouly AC; Huang H; Girard L; MacDonald RJ; Brekken RA; Wilkie TM
    Sci Rep; 2020 Nov; 10(1):20662. PubMed ID: 33244070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked.
    Hannes S; Abhari BA; Fulda S
    Cancer Lett; 2016 Sep; 380(1):31-8. PubMed ID: 27267809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models.
    Zhu Y; Knolhoff BL; Meyer MA; Nywening TM; West BL; Luo J; Wang-Gillam A; Goedegebuure SP; Linehan DC; DeNardo DG
    Cancer Res; 2014 Sep; 74(18):5057-69. PubMed ID: 25082815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of p21 activated kinase enhances tumour immune response and sensitizes pancreatic cancer to gemcitabine.
    Wang K; Huynh N; Wang X; Baldwin G; Nikfarjam M; He H
    Int J Oncol; 2018 Jan; 52(1):261-269. PubMed ID: 29115428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caspase blockade induces RIP3-mediated programmed necrosis in Toll-like receptor-activated microglia.
    Kim SJ; Li J
    Cell Death Dis; 2013 Jul; 4(7):e716. PubMed ID: 23846218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis.
    Karl I; Jossberger-Werner M; Schmidt N; Horn S; Goebeler M; Leverkus M; Wajant H; Giner T
    Cell Death Dis; 2014 Oct; 5(10):e1444. PubMed ID: 25299769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RIP1, RIP3, and MLKL Contribute to Cell Death Caused by Clostridium perfringens Enterotoxin.
    Shrestha A; Mehdizadeh Gohari I; McClane BA
    mBio; 2019 Dec; 10(6):. PubMed ID: 31848291
    [No Abstract]   [Full Text] [Related]  

  • 20. RIP3 mediates the embryonic lethality of caspase-8-deficient mice.
    Kaiser WJ; Upton JW; Long AB; Livingston-Rosanoff D; Daley-Bauer LP; Hakem R; Caspary T; Mocarski ES
    Nature; 2011 Mar; 471(7338):368-72. PubMed ID: 21368762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.